A randomized, controlled, multi‐center trial of the efficacy and safety of the Occlutech Figulla Flex‐II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects.

MLA

Kenny, Damien, et al. “A Randomized, Controlled, Multi‐center Trial of the Efficacy and Safety of the Occlutech Figulla Flex‐II Occluder Compared to the Amplatzer Septal Occluder for Transcatheter Closure of Secundum Atrial Septal Defects.” Catheterization & Cardiovascular Interventions, vol. 93, no. 2, Feb. 2019, pp. 316–21. EBSCOhost, https://doi.org/10.1002/ccd.27899.

APA

Kenny, D., Eicken, A., Dähnert, I., Boudjemline, Y., Sievert, H., Schneider, M. B., Gori, T., & Hijazi, Z. M. (2019). A randomized, controlled, multi‐center trial of the efficacy and safety of the Occlutech Figulla Flex‐II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects. Catheterization & Cardiovascular Interventions, 93(2), 316–321. https://doi.org/10.1002/ccd.27899

Chicago

Kenny, Damien, Andreas Eicken, Ingo Dähnert, Younes Boudjemline, Horst Sievert, Martin BE Schneider, Tommaso Gori, and Ziyad M. Hijazi. 2019. “A Randomized, Controlled, Multi‐center Trial of the Efficacy and Safety of the Occlutech Figulla Flex‐II Occluder Compared to the Amplatzer Septal Occluder for Transcatheter Closure of Secundum Atrial Septal Defects.” Catheterization & Cardiovascular Interventions 93 (2): 316–21. doi:10.1002/ccd.27899.